is pSivida Corp. Trending?
Drug Manufacturers

According to the aggregate analysts rating, pSivida Corp. (NASDAQ:$PSDV) currently sits at an average rating of ‘Buy’. This rating is determined by analysts who look at a combination of wave theory, momentum, and volatility to …

Read

Pharmaceutical
window.googletag = window.googletag || {cmd: []};googletag.cmd.push(function() {googletag.defineSlot(‘/59672724/native-msc-instream-1’, [‘fluid’], ‘gpt-passback’).addService(googletag.pubads());googletag.enableServices();googletag.display(‘gpt-passback’);});On Friday, August 4th, the infamous “Pharma bro” Martin Shkreli was found guilty of three counts of securities fraud. However, he was found not guilty of five other … Read
Pharmaceutical
window.googletag = window.googletag || {cmd: []};googletag.cmd.push(function() {googletag.defineSlot(‘/59672724/native-msc-instream-1’, [‘fluid’], ‘gpt-passback’).addService(googletag.pubads());googletag.enableServices();googletag.display(‘gpt-passback’);});On Tuesday, after Jay Olson, an analyst at Oppenheimer, upgraded TherapeuticsMD (NYSEMKT:$TXMD) stock from “Perform” to “Outperform”, shares of TXMD increased 18%. Additionally, the analyst gave TherapeuticsMD shares … Read